This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
April 11, 2013 /PRNewswire/ --
ArcDia International Ltd, the manufacturer of world's only multianalyte point-of-care diagnostic system for respiratory tract infections, is pleased to announce the strengthening of its management team and customer operations with the appointment of
Jesper Floyd Kristiansen as VP Sales and Marketing.
Prior the appointment, Mr. Kristiansen held various management positions at Dako, the leading company for cancer diagnostics. He has worked as Business Director and Country Manager responsible for P&L and sales operations in the
Central East Europe,
"ArcDia's mariPOC®is the first and only product on the market to allow efficient testing of infectious diseases at the point-of care.ArcDia has during the last couple of years participatedinthe most relevant trade fairs and congresses, and as late asJanuarymariPOC®was presented at the Arab Health inDubaiwith a huge interest from both potential distributors and end-users. I am excitedto join the ArcDia team and to expand mariPOC®business in the international markets", says
Jesper Kristiansen, VP Sales and Marketing, ArcDia Ltd.
We are pleased to welcome Mr.Kristiansen to join the ArcDia team. He brings his experience and knowledge in international sales of IVD productsto build up the distributionchannelsand customer operationsforthemariPOC®product line", says Dr.
Aleksi Soini, CEO of ArcDia Ltd.
Earlier in 2012, ArcDia announced collaboration agreement with Laboratories LETI for
Portugal. ArcDia's products have been in daily clinical practice since 2011.
® provides multianalyte diagnostic results for influenza like illnesses and tonsillitis in near patient settings in 20 minutes. The mariPOC
® applications are targeted to acute respiratory infections, which represents the most common infectious diseases on Earth.
® is superior in performance to the conventional test methods, including lateral flow rapid tests and standard culturing. mariPOC
® is designed to improve patient management, quality of health care, and to allow pathogen specific timely diagnostics and medication to all patients. mariPOC
® was launched to the European market in late 2010.